Weaver Consulting Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Weaver Consulting Group's AMGN Position: Q2 2026 in Review
Weaver Consulting Group reduced its Amgen (AMGN) stake by 6.7% in Q2 2026, selling an estimated $40.1K and leaving 1,633 shares worth $591K. The position accounts for 0.12% of the portfolio, ranked #147.
Weaver Consulting Group first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. The position peaked at $616K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Weaver Consulting Group held 1,633 shares of Amgen worth $591K as of Q2 2026.
- Weaver Consulting Group sold 117 Amgen shares in Q2 2026, an estimated $40.1K.
- Amgen made up 0.12% of Weaver Consulting Group's portfolio in Q2 2026, its #147 holding.
- Weaver Consulting Group first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
- Weaver Consulting Group's Amgen position peaked at $616K in Q1 2026.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Weaver Consulting Group's 13F filing for Q2 2026, filed 29 Jul 2026.